GemViz Receives Investment From Elevate Ventures’ Community Ideation Fund
March 29, 2023 at 9:22 p.m.
By Staff Report-
The CIF is designed to support early-stage companies in Indiana who are committed to making a positive impact on their local community. GemViz's selection for the investment is a testament to the company's dedication to improving healthcare outcomes and its potential to create jobs and stimulate economic growth in the area, according to a news release provided by Kosciusko Economic Development Corporation (KEDCO).
"We are thrilled to receive this funding from Elevate Ventures' CIF program," said Mike Cusick, CEO of GemViz LLC. "This will enable us to advance our technology and bring it one step closer to benefiting patients and healthcare providers. We are thankful for the support available in our community for early-stage start-ups to bring innovative products to market."
"Our team at KEDCO is excited to see the progress GemViz is making since participating in our MedTech Accelerator Studio last year," said KEDCO CEO Alan Tio. "We will continue to work alongside partners like Elevate Ventures to identify tools in our economic development toolbox to support the company’s plans moving forward."
GemViz LLC's platform is designed to securely integrate all available patient data sources and has the potential to improve diagnostic accuracy and optimize treatment plans. By driving patient engagement and leveraging real-time patient data, this technology can enable healthcare providers to make informed decisions, resulting in better clinical outcomes and improved patient satisfaction.
"Gemviz is enhancing the physician’s understanding of the patient, driving better interactions, diagnosis and outcomes," said Dan Meek, entrepreneur-in-residence for Elevate Ventures.
GemViz LLC's receipt of the CIF is a significant milestone in the company's journey toward bringing its solution to market, the news release states. The company plans to use the award to deliver a functional prototype and engage customers for product insights.
Latest News
E-Editions
The CIF is designed to support early-stage companies in Indiana who are committed to making a positive impact on their local community. GemViz's selection for the investment is a testament to the company's dedication to improving healthcare outcomes and its potential to create jobs and stimulate economic growth in the area, according to a news release provided by Kosciusko Economic Development Corporation (KEDCO).
"We are thrilled to receive this funding from Elevate Ventures' CIF program," said Mike Cusick, CEO of GemViz LLC. "This will enable us to advance our technology and bring it one step closer to benefiting patients and healthcare providers. We are thankful for the support available in our community for early-stage start-ups to bring innovative products to market."
"Our team at KEDCO is excited to see the progress GemViz is making since participating in our MedTech Accelerator Studio last year," said KEDCO CEO Alan Tio. "We will continue to work alongside partners like Elevate Ventures to identify tools in our economic development toolbox to support the company’s plans moving forward."
GemViz LLC's platform is designed to securely integrate all available patient data sources and has the potential to improve diagnostic accuracy and optimize treatment plans. By driving patient engagement and leveraging real-time patient data, this technology can enable healthcare providers to make informed decisions, resulting in better clinical outcomes and improved patient satisfaction.
"Gemviz is enhancing the physician’s understanding of the patient, driving better interactions, diagnosis and outcomes," said Dan Meek, entrepreneur-in-residence for Elevate Ventures.
GemViz LLC's receipt of the CIF is a significant milestone in the company's journey toward bringing its solution to market, the news release states. The company plans to use the award to deliver a functional prototype and engage customers for product insights.
Have a news tip? Email [email protected] or Call/Text 360-922-3092